Status:
TERMINATED
Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone Deficiency
Lead Sponsor:
Pfizer
Conditions:
Growth Hormone Deficiency
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The study will investigate the effect on growth hormone replacement in patients with isolated growth hormone deficiency on body composition, especially visceral fat mass.
Detailed Description
The study was terminated on 15-Dec-2008 due to poor recruitment. Although 9 Patients were enrolled, no patient was randomized nor treated with somatropin. No safety reasons contributed to the terminat...
Eligibility Criteria
Inclusion
- Males and females between 18 and 65 years of age
- Isolated growth hormone deficiency
Exclusion
- Isolated growth hormone deficiency by childhood onset
- Diabetes mellitus type 1 or 2
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00630487
Start Date
May 1 2008
End Date
October 1 2008
Last Update
March 4 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Bad Aibling, Germany, 83043
2
Pfizer Investigational Site
München, Germany, 80804